Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long‐Term Registry: bridging between EMA/FDA label, the PARADIGM‐HF trial, ESC Guidelines, and real‐world

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long‐Term Registry: bridging between EMA/FDA label, the PARADIGM‐HF trial, ESC Guidelines, and real‐world
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-27
DOI
10.1002/ejhf.1532

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.